AORTIC MOLDING AND OCCLUSION BALLOON CATHETER (MOB) MOB37

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative report with the FDA on 2020-03-26 for AORTIC MOLDING AND OCCLUSION BALLOON CATHETER (MOB) MOB37 manufactured by W.l. Gore & Associates.

Event Text Entries

[185614817] Pma/510(k) #k172567. A review of the manufacturing records for the device(s) verified that the lot(s) met all pre-release specifications.
Patient Sequence No: 1, Text Type: N, H10


[185614818] On (b)(6) 2020, this patient underwent endovascular treatment for an abdominal aortic aneurysm and was implanted with gore? Excluder? Aaa endoprostheses featuring? Delivery system. The trunk ipsilateral leg component was advanced into position via a gore? Dryseal flex introducer sheath; however when deployed, the introducer sheath had not been completely withdrawn back to the light colored shaft marker on the delivery catheter and the ipsilateral leg deployed within the sheath. The physician then chose to cannulate the contralateral gate with the sheath still in place but met with difficulty due to the narrowness of the date due to patient anatomy. After multiple attempts, successful cannulation of the gate was achieved and the delivery catheter was removed from the patient. The physician then cut the trailing end of the (locking mechanism) of the dilator of the sheath and inserted it from the trailing and pushed the ipsilateral leg out of the sheath and successfully deployed in the left common iliac artery. Post deployment of all the devices touch up angioplasty was performed throughout the entire system with a gore? Molding & occlusion balloon. Final angiography was performed and identified a type ii endoleak and a dissection immediately proximal to the trunk. A gore? Aortic extender component was implanted proximally to extend coverage and treat the dissection. At the conclusion of the procedure a slight dissection remained. The physician reported that the dissection may have been caused by calcification in the patient's proximal neck, touch up angioplasty and the complications associated with the ipsilateral leg deployment. The patient tolerated the procedure and will be monitored by the physician.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3007284313-2020-00079
MDR Report Key9886843
Report SourceCOMPANY REPRESENTATIVE
Date Received2020-03-26
Date of Report2020-03-13
Date of Event2020-03-13
Device Manufacturer Date2019-10-10
Date Added to Maude2020-03-26
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactLAURA CRAWFORD
Manufacturer Street1500 N. 4TH STREET
Manufacturer CityAZ
Manufacturer Phone9285263030
Manufacturer G1MEDICAL PHOENIX 1 B/P
Manufacturer Street32360 N. NORTH VALLEY PARKWAY
Manufacturer CityPHOENIX AZ 85085
Manufacturer CountryUS
Manufacturer Postal Code85085
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameAORTIC MOLDING AND OCCLUSION BALLOON CATHETER (MOB)
Generic NameCATHETER, PERCUTANEOUS
Product CodeDQY
Date Received2020-03-26
Model NumberMOB37
Catalog NumberMOB37
Lot Number21409738
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerW.L. GORE & ASSOCIATES
Manufacturer AddressFLAGSTAFF AZ


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Other 2020-03-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.